(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALECSAT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALECSAT

ST13

US500000079245157

Class

5, 10, 42, 44

Filing

79245157

Registration

5847726

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

03/21/2026

Trademark type

Word

Nice classes

5, 10, 42, 44

Filing date

09/28/2018

Registration date

09/03/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/20/2026

Last transaction

03/21/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

84

Owner location

DK

Examiner

MACFARLANE, JAMES W

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CYTOVAC A/S

Representatives

Lisa M. Martens Sheppard Mullin Richter & Hampton LLP

Technical classification

Nice Classes

Class 5Class 10Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicine for the treatment of immune system related diseases and disorders; pharmaceuticalmedical and veterinary medical preparations for the treatment of immune system related diseases and disorders

Class 10

Medical apparatus and instruments for treating immune system related diseases and disorders

Class 42

Scientific research and development

Class 44

Medical examinations relating to the treatment of humansmedical care

Publications

History of USPTO decisions and trademark events.

32 publications found

C71T

CANCELLED SECTION 71

03/20/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

09/03/2024

IRRH

IRREGULARITY FROM IB EXAMINED BY MPU

02/06/2020

IRFI

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

01/27/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/04/2020

FIMP

FINAL DISPOSITION PROCESSED

01/04/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/03/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

09/03/2019

GPNX

NOTIFICATION PROCESSED BY IB

07/12/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/18/2019

PUBO

PUBLISHED FOR OPPOSITION

06/18/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/29/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/29/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/29/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/11/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2019

ALIE

ASSIGNED TO LIE

05/06/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/26/2019

FINT

FINAL DECISION TRANSACTION PROCESSED BY IB

03/01/2019

RFNT

REFUSAL PROCESSED BY IB

02/22/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/31/2019

RFRR

REFUSAL PROCESSED BY MPU

01/31/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/18/2019

CNRT

NON-FINAL ACTION WRITTEN

01/17/2019

DOCK

ASSIGNED TO EXAMINER

01/09/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/28/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/28/2018

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

12/15/2018

MAFR

APPLICATION FILING RECEIPT MAILED

11/17/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/13/2018

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

11/08/2018

Continuous trademark protection

Get notified about every new filing that threatens ALECSAT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.